Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Neha Panjwani

Insulet Stock Outlook: Is Wall Street Bullish or Bearish?

Insulet Corporation (PODD), headquartered in Acton, Massachusetts, operates as an innovative medical device company. Valued at $19.8 billion by market cap, the company develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes.

Shares of this insulin infusion systems maker have outperformed the broader market over the past year. PODD has gained 53.9% over this time frame, while the broader S&P 500 Index ($SPX) has rallied nearly 17.6%. In 2025, PODD stock is up 8.6%, surpassing the SPX’s 1.7% rise on a YTD basis. 

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.